Case Report: Novel CXCR2 compound heterozygous variants in an infant with neutropenia - Summary - MDSpire

Case Report: Novel CXCR2 compound heterozygous variants in an infant with neutropenia

  • By

  • Hua Liu

  • Yinzhu Zhang

  • Xiao Liu

  • Jiayue Qin

  • Chunyi Zhang

  • Junjin Huang

  • Danyang Zhang

  • Hebing Zhou

  • Ming Yang

  • Yan Yue

  • May 29, 2026

  • 0 min

Share

Objective:

Revise to include direct attribution.

Key Findings:
  • Ensure all findings are directly sourced.
Interpretation:

Remove or rephrase to avoid unsupported conclusions.

Limitations:
  • Link limitations directly to the source material.
Conclusion:

Revise to reflect findings without editorial interpretation.

Original Source(s)

Case Report: Novel CXCR2 compound heterozygous variants in an infant with neutropenia

  • by Hua Liu, Yinzhu Zhang, Xiao Liu, Jiayue Qin, Chunyi Zhang, Junjin Huang, Danyang Zhang, Hebing Zhou, Ming Yang, Yan Yue

  • May 29, 2026

Related Content

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

Primary central nervous system lymphoma and tumefactive demyelinating lesions in multiple sclerosis: a retrospective observational cohort study

This Week’s Biopharma News: ADCs, Biosimilars, and Microbiome Moves

Merck’s TROP2 ADC delivers a phase III win in endometrial cancer, as new golimumab biosimilars and an oral microbiome therapy move forward

  • May 26, 2026

  • 9 min